Image pharmaphorum Editor Debates & Insight Sponsored Available on demand: Customer data is the lifeblood of comme... Findings from the Veeva 2015 European Life Sciences Survey Debates & Insight Sponsored Next-generation brand launches: Global health data and insig... Life Sciences companies face challenges today in achieving their revenue forecast and return on investment from brand launches. Debates & Insight Sponsored Patient centricity: What it means and why it’s important to ... Having clear parameters of patient‑centricity that can be measured year-on-year enables Boehringer Ingelheim UK to know if it is moving in the right direction and to set targets for what it hop Debates & Insight Sponsored Available on demand: Improving patient adherence, engagement... Load more results
Debates & Insight Sponsored Available on demand: Customer data is the lifeblood of comme... Findings from the Veeva 2015 European Life Sciences Survey
Debates & Insight Sponsored Next-generation brand launches: Global health data and insig... Life Sciences companies face challenges today in achieving their revenue forecast and return on investment from brand launches.
Debates & Insight Sponsored Patient centricity: What it means and why it’s important to ... Having clear parameters of patient‑centricity that can be measured year-on-year enables Boehringer Ingelheim UK to know if it is moving in the right direction and to set targets for what it hop
News MSD takes a $400m bite of SciBrunch's KRAS drug MSD has signed a license agreement for a KRAS G12D inhibitor from China's SciBrunch, paying $400m upfront for the preclinical candidate.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
